Compounds > phenoxybenzamine
Page last updated: 2024-11-02

phenoxybenzamine and Dyslipidemias

phenoxybenzamine has been researched along with Dyslipidemias in 1 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navarro, I1
Molina, M1
Civera, M1
Ascaso, JF1
Real, JT1
Carmena, R1

Reviews

1 review available for phenoxybenzamine and Dyslipidemias

ArticleYear
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:4

    Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamin

2011